📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Should the two-trial paradigm still be the gold standard in drug assessment? (2023)

First Author: Zhan SJ

Attributed to: Innovative statistical methods for clinical trial pathways supporting regulatory drug approval funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/pst.2262

PubMed Identifier: 36054079

Publication URI: http://europepmc.org/abstract/MED/36054079

Type: Journal Article/Review

Volume: 22

Parent Publication: Pharmaceutical statistics

Issue: 1

ISSN: 1539-1604